You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABI-009

Showing 1 - 25 of 376
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Hypertension Trial in United States (ABI-009, nab-rapamycin, albumin-bound rapamycin)

Active, not recruiting
  • Pulmonary Hypertension
  • ABI-009, nab-rapamycin, albumin-bound rapamycin
  • Tucson, Arizona
  • +5 more
Aug 22, 2022

High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma Trial in Fullerton, Newport Beach, Santa Monica (ABI-009,

Active, not recruiting
  • High Grade Recurrent Glioma and Newly Diagnosed Glioblastoma
  • ABI-009
  • +5 more
  • Fullerton, California
  • +2 more
Jun 13, 2022

PEComa, Malignant, TSC1, TSC2 Trial (ABI-009)

Approved for marketing
  • PEComa, Malignant
  • +3 more
  • ABI-009
  • (no location specified)
Mar 2, 2022

PEComa Trial in United States (ABI-009)

Completed
  • PEComa
  • ABI-009
  • Palo Alto, California
  • +8 more
Apr 29, 2022

Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Seattle

Recruiting
  • Advanced Soft Tissue Sarcoma
  • +2 more
  • Nanoparticle Albumin-Bound Rapamycin
  • Pazopanib hydrochloride
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Endometrial Cancer, Endometrioid Tumor, Cancer Trial in Oklahoma City (nab-sirolimus)

Not yet recruiting
  • Endometrial Cancer
  • +5 more
  • Oklahoma City, Oklahoma
    University Oklahoma Stephenson Cancer Center
Aug 16, 2023

Non-muscle Invasive Bladder Cancer (NMIBC) Trial in New York, Nashville (ABI-009, Gemcitabine)

Completed
Has Results
  • Non-muscle Invasive Bladder Cancer (NMIBC)
  • New York, New York
  • +1 more
May 12, 2021

Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

Not yet recruiting
  • Solid Tumor, Adult
  • +4 more
  • (no location specified)
Apr 24, 2023

Neuroendocrine Tumors Trial in New Orleans (ABI-009)

Terminated
Has Results
  • Neuroendocrine Tumors
  • ABI-009
  • New Orleans, Louisiana
    Ochsner Clinic Foundation
May 17, 2021

Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor Trial in Newport Beach, Denver, Dallas (nab-sirolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +4 more
  • Newport Beach, California
  • +2 more
Aug 16, 2023

Epilepsy Intractable Trial in Seattle (ABI-009)

Unknown status
  • Epilepsy Intractable
  • ABI-009
  • Seattle, Washington
    Seattle Children's Hospital
Oct 19, 2020

Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan

Active, not recruiting
  • Childhood Solid Neoplasm
  • +4 more
  • Irinotecan Hydrochloride
  • +4 more
  • Birmingham, Alabama
  • +20 more
Feb 1, 2023

Solid Tumors Trial in Santa Monica, Houston (ABI-009)

Completed
  • Solid Tumors
  • ABI-009
  • Santa Monica, California
  • +1 more
Oct 16, 2019

Multiple Myeloma Trial in Boston (ABI-009, Pomalidomide, Dexamethasone)

Withdrawn
  • Multiple Myeloma
  • ABI-009
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 12, 2019

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial in United States

Recruiting
  • Non Small Cell Lung Cancer
  • +11 more
  • Denver, Colorado
  • +3 more
Jan 10, 2023

Acquired Brain Injury Trial (ABI-motion program)

Not yet recruiting
  • Acquired Brain Injury
  • ABI-motion program
  • (no location specified)
Sep 21, 2023

Peripheral Artery Disease Trial in Shanghai (Drug eluting stent, drug coating balloon)

Recruiting
  • Peripheral Artery Disease
  • Drug eluting stent
  • drug coating balloon
  • Shanghai, Shanghai, China
    Changhai Hospital of Shanghai
Mar 20, 2023

Myopia, Progressive Trial (CBT-009, Vehicle, Atropine Sulfate)

Completed
  • Myopia, Progressive
  • Brisbane, Australia
    USC
Jan 25, 2023

Osteoporosis, Postmenopausal Trial in Port Saint Lucie (TVB-009, Prolia®)

Active, not recruiting
  • Osteoporosis, Postmenopausal
  • TVB-009
  • Prolia®
  • Port Saint Lucie, Florida
    Site 10101
Feb 1, 2023

CLL/SLL, NHL, Mantle Cell Lymphoma Trial in United States (SYNCAR-001, STK-009, Cyclophosphamide)

Recruiting
  • CLL/SLL
  • +6 more
  • Duarte, California
  • +4 more
Jan 12, 2023

Asymptomatic Peripheral Artery Disease in Type 1 Diabetes

Completed
  • Type 1 Diabetes Mellitus
  • Peripheral Artery Disease
    • Madrid, Spain
      Diabetes, Obesity and Human Reproduction Research Group, Departm
    Mar 21, 2022

    Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory

    Completed
    • Advanced Malignant Neoplasm
    • +31 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Scottsdale, Arizona
    • +1 more
    Jun 5, 2019

    Glaucoma, Vision Impairment and Blindness, Cataract Trial in New York (Intervention Using Patient Navigators, Usual Care Without

    Not yet recruiting
    • Glaucoma
    • +3 more
    • Intervention Using Patient Navigators
    • Usual Care Without Patient Navigators
    • New York, New York
      Columbia University Irving Medical Center - 622 W. 168th St. Flo
    Aug 7, 2023

    Acquired Brain Injury, Fatigue Trial (e-COGRAT (a blended eHealth intervention))

    Not yet recruiting
    • Acquired Brain Injury
    • Fatigue
    • e-COGRAT (a blended eHealth intervention)
    • (no location specified)
    May 8, 2023